Bohlig Tamara N
Known title: DirectorCIK: 0001787292
Associated companies
Transaction History
| AX | ▼ Sell | Open Market | 2,145 | $185K | 12/8/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 4,289 | $339K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Other | 2,144 | $170K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Other | 2,999 | $208K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,000 | $139K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $417K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Other | 999 | $69K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Open Market | 2,000 | $107K | 2/14/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,000 | $86K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 2,667 | $115K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 999 | $43K | 8/31/2023 | View on chart |
| AX | ▼ Sell | Other | 1,333 | $57K | 8/31/2023 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $249K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Other | 3,000 | $124K | 8/15/2023 | View on chart |
| AX | ▼ Sell | Open Market | 2,978 | $121K | 9/1/2022 | View on chart |
| AX | ▲ Buy | Option Exercise | 5,954 | $249K | 8/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Axos Financial Faces Valuation Debate Amid Analyst Support
Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.
Axos Financial Faces Valuation Debate Amid Analyst Support. Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.